EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression

Genta Kakiyama, Nanah Bai-Kamara, Daniel Rodriguez-Agudo, Hajime Takei, Kei Minowa, Michael Fuchs, Sudha Biddinger, Jolene J Windle, Mark A Subler, Tsuyoshi Murai, Mitsuyoshi Suzuki, Hiroshi Nittono und 2 weitere

Journal of Lipid Research · 2025

DOI: 10.1016/j.jlr.2025.100757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Genta Kakiyama und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Research Services, Central Virginia Veterans…. Hauptthemen laut MEDLINE: Diet, Western, Liver, Disease Progression, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BLRD VA, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effect of liver specific oxysterol 7α-hydroxylase (CYP7B1) overexpression on the Western diet (WD)-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression was studied in mice. Among various hepatic genes impacted during MASLD development, CYP7B1 is consistently suppressed in multiple MASLD mouse models and in human MASLD cohorts. CYP7B1 enzyme suppression leads to accumulations of bioactive oxysterols such as ( 25R )26-Hydroxycholesterol (26HC) and 25-hydroxycholesterol (25HC). We challenged liver specific CYP7B1 transgenic (CYP7B1 hep.tg ) overexpressing mice with ad libitum WD feeding. Unlike their wild type (WT) counterparts, WD-fed CYP7B1 hep.tg mice developed no significant hepatotoxicity as evidenced by liver histology, lipid quantifications, and serum biomarker analyses. Hepatic 26HC and 25HC levels were maintained at the basal levels. The comparative gene expression/lipidomic analyses between WT and CYP7B1 hep.tg mice revealed that chronically accumulated 26HC initiates LXR/PPAR-mediated hepatic fatty acid uptake and lipogenesis which surpasses fatty acid metabolism and export; compromising metabolic functions. In addition, major pathways related to oxidative stress, inflammation and immune system including retinol metabolism, arachidonic acid metabolism and linoleic acid metabolism were significantly impacted in the WD-fed WT mice. All pathways were unaltered in CYP7B1 hep.tg mice liver. Furthermore, the nucleus of WT mouse liver but not of CYP7B1 hep.tg mouse liver accumulated 26HC and 25HC in response to WD. This data strongly suggested these two oxysterols are specifically important in nuclear transcriptional regulation for the described cytotoxic pathways. In conclusion, this study represents a “proof-of-concept” that maintaining normal mitochondrial cholesterol metabolism with hepatic CYP7B1 expression prevents oxysterol-driven liver toxicity; thus attenuating MASLD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, WesternLiverDisease Progression25-Hydroxyvitamin D3 1-alpha-HydroxylaseFatty LiverCytochrome P450 Family 7AnimalsMice, TransgenicMiceMaleHumansSteroid Hydroxylases

Stichwörter der Autor:innen

CD36cholesterolinflammationlipotoxicitylivermitochondriaoxysterol

Substanzen

25-Hydroxyvitamin D3 1-alpha-HydroxylaseCyp7b1 protein, mouseCytochrome P450 Family 7Steroid Hydroxylases

Autor:innen und Institutionen

  • Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Research Services, Central Virginia Veterans Affairs Health Care System, Richmond, VA, USA. Electronic address: ge…
  • Research Services, Central Virginia Veterans Affairs Health Care System, Richmond, VA, USA.
  • Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Research Services, Central Virginia Veterans Affairs Health Care System, Richmond, VA, USA.
  • Junshin Clinic Bile Acid Institute, Meguro-ku, Tokyo, Japan.
  • Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Research Services, Central Virginia Veterans Affairs Health Care System, Richmond, VA, USA; Department of Pediatri…
  • Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, MA, USA.

Förderung

  • BLRD VA
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • U.S. Department of Veterans Affairs
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Kakiyama, G., Bai-Kamara, N., Rodriguez-Agudo, D., Takei, H., Minowa, K., Fuchs, M., Biddinger, S., Windle, J. J., Subler, M. A., Murai, T., Suzuki, M., Nittono, H., Sanyal, A., & Pandak, W. M. (2025). Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100757

Vancouver

Kakiyama G, Bai-Kamara N, Rodriguez-Agudo D, Takei H, Minowa K, Fuchs M, et al. Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100757

BibTeX
@article{Kakiyama2025,
  author = {Kakiyama, Genta and Bai-Kamara, Nanah and Rodriguez-Agudo, Daniel and Takei, Hajime and Minowa, Kei and Fuchs, Michael and Biddinger, Sudha and Windle, Jolene J and Subler, Mark A and Murai, Tsuyoshi and Suzuki, Mitsuyoshi and Nittono, Hiroshi and Sanyal, Arun and Pandak, William M},
  title = {Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression},
  journal = {Journal of Lipid Research},
  year = {2025},
  doi = {10.1016/j.jlr.2025.100757}
}
Kostenlos starten →